-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, Motq6zb5ojNjWr4YVAAnKuOOhx1jXv5fSuJ/cMhq3pmfMbNrlYz8BI6zHR7Qrl5s QqhMq6XFltZIwfKvsxN4lA== 0000000000-10-007101.txt : 20100415 0000000000-10-007101.hdr.sgml : 20100415 20100204094443 ACCESSION NUMBER: 0000000000-10-007101 CONFORMED SUBMISSION TYPE: UPLOAD PUBLIC DOCUMENT COUNT: 1 FILED AS OF DATE: 20100204 FILED FOR: COMPANY DATA: COMPANY CONFORMED NAME: PHARMATHENE, INC CENTRAL INDEX KEY: 0001326190 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 202726770 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: UPLOAD BUSINESS ADDRESS: STREET 1: ONE PARK PLACE, SUITE 450 CITY: ANNAPOLIS STATE: MD ZIP: 21401 BUSINESS PHONE: 410 269 2600 MAIL ADDRESS: STREET 1: ONE PARK PLACE, SUITE 450 CITY: ANNAPOLIS STATE: MD ZIP: 21401 FORMER COMPANY: FORMER CONFORMED NAME: HEALTHCARE ACQUISITION CORP DATE OF NAME CHANGE: 20050505 PUBLIC REFERENCE ACCESSION NUMBER: 0001104659-09-021825 LETTER 1 filename1.pdf begin 644 filename1.pdf M)5!$1BTQ+C0-)>+CS],-"CD@,"!O8FH-/#PO3&EN96%R:7IE9"`Q+TP@,3$P M-#8O3R`Q,2]%(#0U-C`O3B`R+U0@,3`X,C`O2"!;(#4U-B`Q.#==/CX-96YD M;V)J#2`@("`@("`@("`@("`@("`@("`@#0IXF4@ M,C(O4')E=B`Q,#@Q,"]2;V]T(#$P(#`@4B]);F9O(#@@,"!2+TE$6SPR140S M,#)#0C8X1$(P1C-!0T4R-T$Q,S8P,49$035%,#X\141$,S7!E+T-A=&%L;V2A4:6UE7!E+T5X=$=3=&%T92]302!F86QS92]332`P M+C`R/CX-96YD;V)J#3$V(#`@;V)J#3P\+TQE;F=T:"`Q-34U+T9I;'1E/&:C,=3Q]@";)04R1#D%']&_WB[@(D15V<3IV)1!'$[MFS9W?!-S_=+G@+,AA M>7U\(SZ[<_D1%@1!2C87_=5^]N#]KB7"%R+@P1&(^`3%>>!G2!:C9[H*[;9W6]D4RL`5@\]*E_BKA=O;VTN8LY&TS&%^ MM]5JXX2C7GV(_`]&CNT/_NJMVJ4LWAMERQ MLZ@^E0KN9/,,=X5DHGPC)]\0M3MUP9F(\IZFS^HM'`7F$1*XOP)$D\ZD7A+S#Y:&MR M=5,U.^#!XF?85`V@1?A#R0;>EVNUAFOE+Q*D>_>(C(=\#H*2=:K=:0Z=X8`E MDZO!Q:^CBSO5Z&K=.[E7==M["*R'_!5AHK[C0=TW5%).T[]4K+_"2!>AB+/T M4GGM#R3W/<*M9Z^JYYJ(^-@8N`IXQW!FR:"EUFZHHJKTNGZ!_BN+F M.8O"^#M`#0.L/PN/MB$ZW(E%LL>^Z"]BEGO&7Z!4GHD("J1NJF]ZK0;,SOZ! MW`>O,[#7[19TB:(B@[+554E;'QWJ#L75F);`6W('0B,^`7J2\@=OK24LM9N!KITQK+/B197)T1+/HRQ`Q4MXQ M8P=OR!>MK*UYIR7M97FPEDX MZEX)17^(V8\Q`QCGWD^IUQ8%%%7U#(5^=M,+796MWKQ8V[)$K0Z<9@=&HX%1 MWDN^@`H-1UY#O1O;PE>4..:G>(&-+E!'B4?"R1"EQ9!0L1'GEYM M#Y1F)_5E=>812;IL%4)$:C<:LXZ_5T6'U.B6N9[..8/I9E;+F\WENQU M!675HH8*K:SB96MI/#6Q&-V/*O>(ZD-&01LHL12-P9*>NQR(D*7IA1S8^>EJ MKRZ41&6HO^M"(A,NC=*@%O!7CR(,7J\USXI]Z`D8_-6&JL$UFB&,)(\O9$SD M+F-8VQ?%V,MM;]-U?0UACNXUY*20@]!.@.MS9SL-P[U[M3E=K"S@>!FR=B\ M3\:O&\Q!?,;Q,$G__]2T``ZS1W`6]U5S.D06;HT0B-,3'X]?[5P?92F?U-B> MD)BR_ M@\LGX-*`<70;8?]"=(DU<(Y.A':=IX+1P>D"-BYLE5]&=_:Z<;7ZVND&I7=+ M-95ZB[NFHLZ#:?(C?/\P*,ZACY+E9#))^@E-2;W&EE=4-6DHH@'=!Q@+N[&/ M,!*48Y$F+/].A&%BUWD4L>ARA-@+@^PT0-3/Y!9G?5DFKFBH9H.CX[(X7;@R MV*:PUU6=P0G3#V8D!IMG3>\B&WL&L:XBED^/`J,&>7_(K/&,V@RG'"@[HB7T MJ*8K.G7WC;IO^.-)Q5F=EBH?Q23ZD4C]PNBGTD^P5O4&4X1?*XG?6+0^IQ9' M$[%Q=^Q+#_>,^U7@N#062^[5[EFG1=-AAJ5Y.WT'X!=?.S"1_PHP`&6#U,L* M#0IE;F1S=')E86T-96YD;V)J#3$W(#`@;V)J#3P\+U-U8G1Y<&4O5')U951Y M<&4O1F]N=$1E7!E+T9O;G0^/@UE;F1O8FH-,C`@,"!O8FH-/#PO4W1E;58@.#@O1F]N=$YA M;64O07)I86Q-5"]&;VYT4W1R971C:"].;W)M86PO1F]N=%=E:6=H="`T,#`O M1FQA9W,@,S(O1&5S8V5N="`M,C$Q+T9O;G1"0F]X6RTV-C4@+3,R-2`R,#`P M(#$P,#9=+T%S8V5N="`Y,#4O1F]N=$9A;6EL>2A!7!E+T9O;G1$97-C7!E+U!A9V4^/@UE M;F1O8FH-,B`P(&]B:@T\/"]&;VYT/#PO5%0R(#$S(#`@4B]45#0@,3<@,"!2 M+U14-B`Q.2`P(%(^/B]0I%?;CN,V$GWW5]0C%=B, M[K*0I\Y<@@Z0W4&W7X).'FB9MCDC4UY1;H]_8[,?O%4D94ENSV"1G0;&DGBK M.G7J5/''7YXCV)G9SZO9CZM5#!&LMK,HAA#_\*<,H4A37N:P.LQ"V,T6/`S# M!%:5?<*'\XR]VXNVE@8>.#Q)I?&M@\?'1PA6GW'-(N)1!JOWL\E*O_033CX\ M='NIY1P>=<7MHM4/=DZ\M',^RG5[$NT%DCG$813V4VB7^+I?[/83.PFQG9'` M(N99?W)D9X9VDN`TCN[FSEV>EQFZBQ-#FL3`#WLT^#+TPW1.>CTQI&!H/ M1]FJ9@-*PWFOJCT<@B6/F0@6?,DZ'!,U:-E!)5'X3:>(1@X7 MW&I;-V<#V[8Y@%$[KI*_F37Q;Q;%@4#CBN;W'L77J#8#$R M^H8"+XS`BBQ890^6T)VJU%&00=5>Z)UT2-B9L%<]B/DH;*';S02+C%`/,/HQ M:UI$I$8L<#N]FV-@"AS$LR(<;'=*(SQZ`^2]-CU,=N,);:]`TQ-Z7LM769N? M[%IR=0K1#=VJ_X-NT947`]G:(&7*>6"^@-A\/@4Y,P351AD,?LPJQ!)]/VD< MZ*`506IY",+A%O,\'7'O>D986GN/QUHY(EAJ.QK]VUCV@F4E]TX7/$KO,F.< MHF_B_:@W\BMM_Z[1IJG5QH;Y8Y#SS/E5,BUT13QX[G#,15WJSLSA2/G]<1%9 M1SZL9JA/V1)S+84X*WBV!)[;S&SE;$N:-BA9DMKQK`QYY-5L:NXBCGB:C\(X M\6(`R4?B'TU'2K.`Y]/A0.K4;.$9S4=,&&:KS<0.'JH*P]`A]^`3NEHIB4Z@ M_>'8@3RD@,3+G"?H0%:6Y?*>`X4=SW)4M9RLN.="PI?_JPOL"4FL3Q(UNVK0 MXDXU>@`XI87>OB3A"&F$`)??L2].[7B6#.7BQKHH0>C?6#=)'1;_+4VYBG+D M2L:G6@I,YU9N94M,NS2G%M_,L:$LQP_TCJ+0M,Z$G.?1L-M-47EA3A`[T"?D M(EO3GN>&`SQVH`R83M4UG'2%A[:]A-@=)QI23M/LA9WWPJXG?A=,$EW6%YMS ME,4125C$$^8SH*`,@+^$!HD'NB\XY,[#3%PF@P/Y%0Y?HY";M*^@U*[$NI:P ME=+\!UVP2%E](+A>E7]&`,M8Z:]4V2-"R"^P; M6X?.]N#>Y(RD-\,?-+QQ,[U1=@^WTSK`SW7O&9(^^U[Y)4<(Q8W$VN'JKM)R M@ZY]/+5X=CNGZ&.0KF`M_)Z3Z-PV$G]MU5=4);O["06KQ:IHNL6Q/ID%?L0W MW;6BZBQ]LFDUCVQ-98:(MD;G18L&47.`6GIL6DJT7EU=7KCU$WOR*:-?F*A1 M>6WH*D*6%'\((,7.P17R,KK;6'AQQPC;!,"PM6I[`4M"@[4?%JX, M+4%?AWKLD,VMTR[CP>7^Q.3;U8A:+H=Q:,>Q.\CLZ`]`?RX0_1QR^_UXM=LX M[=W(KM')G!L^"FCDJ]J0+]9F;.(:RTG*8K*\E?]"HZG<]6D[;0.M1`\*?5;= M'FF#+>_Z9)#5!FDN+H8,*A':JS+Z]*9"2L_6ER3DR;MRC[E*_KQ,40TR.+_)B[A<0QYG\%N=;*?'5`[LF>"\[H6H,OS/+P*ZU]L0\ M3+Y-`RFZ^@);4:E:61GK#\>.)KK764?>CU M@[C(Z%ZD\"&EFYZF+R%>B/!]:1L;_]#:!_N>8=/,ZG[%Q:V8NQ]GY=B,T9UM M9,O?,O=7.K,&\,3LO8D_O8N(^FW^3JFO=Y[7YN/=Z- M'8O3D<7WM,M3^,$898B[\&ZOY/;6M>L5.;Q)I_YB-53/$7QXN_BO``,`OA&P M9PH-"F5N9'-T7!E+U!A9V5S+TMI9'-;,3$@,"!2(#$@,"!273X^#65N9&]B M:@TW(#`@;V)J#3P\+U-U8G1Y<&4O6$U,+TQE;F=T:"`S-C`W+U1Y<&4O365T M861A=&$^/G-TFMC.60B/SX*/'@Z>&UP;65T82!X;6QN#IX;7!T:STB061O8F4@6$U0($-O&%P+S$N,"\B/@H@("`@("`@("`\>&%P.D-R96%T;W)4;V]L M/E!38W)I<'0U+F1L;"!697)S:6]N(#4N,BXR/"]X87`Z0W)E871O&UL;G,Z9&,](FAT='`Z M+R]P=7)L+F]R9R]D8R]E;&5M96YT"UD969A=6QT(CY-:6-R;W-O9G0@5V]R9"`M M(%!H87)M871H96YE(#(M,RTQ,"!J8G(N9&]C/"]R9&8Z;&D^"B`@("`@("`@ M("`@(#PO&%P34TZ26YS=&%N8V5) M1#YU=6ED.F8X,39A8V$Q+3$R-V(M-#&%P34TZ26YS=&%N8V5)1#X*("`@("`@/"]R9&8Z1&5S8W)I<'1I;VX^"B`@ M(#PO -----END PRIVACY-ENHANCED MESSAGE-----